Directory
>
Andy Deig
Andy Deig
Senior Vice President - Finance | Immunovant
Boston, Massachusetts, United States
Andy Deig
Summary
Andy Deig is a seasoned finance executive currently serving as the Senior Vice President of Finance at Immunovant, where he has been instrumental in driving financial strategy and operational excellence. With a strong background in financial planning and analysis, he has held various leadership roles within the organization, demonstrating a track record of success in managing budgets and cross-functional teams. Prior to his tenure at Immunovant, Andy worked at Eli Lilly, where he gained extensive experience in channel accounts and commercial integration. He holds an MBA from Duke University, specializing in Health Sector Management and Strategy, and a BA in Economics and German from Wabash College. Andy's diverse skill set includes financial modeling, process improvement, and public speaking, making him a well-rounded leader in the finance sector. His commitment to professional development is evident through his continuous engagement in strategic planning and innovation. Outside of work, Andy is passionate about mentoring future finance leaders and contributing to the growth of the finance community.
Andy Deig
Work Experience
Senior Vice President - Finance at
Immunovant
July 2024 - Present
VP - Finance at
Immunovant
July 2023 - July 2024
VP - Financial Planning & Analysis and Chief of Staff to CEO at
Immunovant
May 2021 - June 2023
Advisor - Channel Accounts at
Eli Lilly and Company
August 2020 - May 2021
Commercial Integration Lead at
Eli Lilly and Company
January 2020 - August 2020
District Sales Manager at
Eli Lilly and Company
December 2017 - January 2020
Financial Consultant - Lilly USA at
Eli Lilly and Company
July 2016 - November 2017
Education Leave at
Eli Lilly and Company
June 2014 - July 2016
MBA Candidate at
Duke University The Fuqua School Of Business
January 2014 - May 2016
Market Analytics & Research Intern at
Grifols
January 2015 - January 2016
Senior Financial Analyst - Manufacturing Finance at
Eli Lilly
February 2011 - June 2014
Financial Analyst - Oncology Research at
Eli Lilly
June 2008 - February 2011
Andy Deig
Education
Duke University - The Fuqua School of Business, Master Of Business Administration (M.B.A.)
January 2014 - January 2016
Wabash College, Ba
January 2004 - January 2008
Frequently Asked Questions about Andy Deig
What is Andy Deig email address?
Andy Deig's primary email address is *********@immunovant.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Andy Deig work for?
Andy Deig is a Senior Vice President - Finance at Immunovant, a company specializing in Commercial physical research.
Where Andy Deig graduated from?
Andy Deig holds a degree in Health Sector Management; Strategy from Duke University - The Fuqua School of Business.
How can I directly contact Andy Deig?
To contact Andy Deig directly, you can use the email address *********@immunovant.com. Complete contact information is available upon registration with Muraena.
Who is Andy Deig?
Andy Deig is a seasoned finance executive currently serving as the Senior Vice President of Finance at Immunovant, where he has been instrumental in driving financial strategy and operational excellence. With a strong background in financial planning and analysis, he has held various leadership roles within the organization, demonstrating a track record of success in managing budgets and cross-functional teams. Prior to his tenure at Immunovant, Andy worked at Eli Lilly, where he gained extensive experience in channel accounts and commercial integration. He holds an MBA from Duke University, specializing in Health Sector Management and Strategy, and a BA in Economics and German from Wabash College. Andy's diverse skill set includes financial modeling, process improvement, and public speaking, making him a well-rounded leader in the finance sector. His commitment to professional development is evident through his continuous engagement in strategic planning and innovation. Outside of work, Andy is passionate about mentoring future finance leaders and contributing to the growth of the finance community.
Andy`s contact details
*********@immunovant.com
Colleagues
Non Executive Director
Vice President, Drug Safety and Pharmacovigilance
Vice President, Marketing
Vice President Clinical Operations
VP Clinical Development
Vice President, Clinical Operations and Innovation
Chief Financial Officer
Vice President, Marketing
Vice President CMC Project Management
Senior Vice President, Human Resources